1. Home
  2. FEIM vs ETON Comparison

FEIM vs ETON Comparison

Compare FEIM & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Frequency Electronics Inc.

FEIM

Frequency Electronics Inc.

HOLD

Current Price

$56.56

Market Cap

348.4M

Sector

Industrials

ML Signal

HOLD

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$16.99

Market Cap

498.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEIM
ETON
Founded
1961
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
348.4M
498.8M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
FEIM
ETON
Price
$56.56
$16.99
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$42.50
$29.67
AVG Volume (30 Days)
298.9K
248.4K
Earning Date
12-11-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
163.76
N/A
EPS
2.17
N/A
Revenue
$69,852,000.00
$70,316,000.00
Revenue This Year
N/A
$113.27
Revenue Next Year
$17.90
$36.70
P/E Ratio
$24.69
N/A
Revenue Growth
16.06
102.77
52 Week Low
$13.69
$11.09
52 Week High
$54.45
$23.00

Technical Indicators

Market Signals
Indicator
FEIM
ETON
Relative Strength Index (RSI) 81.66 54.84
Support Level $41.11 $16.27
Resistance Level $54.45 $16.95
Average True Range (ATR) 4.42 0.64
MACD 2.06 0.14
Stochastic Oscillator 90.52 80.00

Price Performance

Historical Comparison
FEIM
ETON

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

Share on Social Networks: